Catalyst Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50
| Closed | -$29.1K | – | 412 |
|
|
2024
Q1 | $29.1K | Hold |
50
| – | – | ﹤0.01% | 289 |
|
|
2023
Q4 | $26.5K | Sell |
50
-270
| -84% | -$131K | ﹤0.01% | 274 |
|
|
2023
Q3 | $162K | Sell |
320
-615
| -66% | -$328K | ﹤0.01% | 199 |
|
|
2023
Q2 | $488K | Sell |
935
-105
| -10% | -$56.7K | 0.01% | 181 |
|
|
2023
Q1 | $599K | Buy |
1,040
+670
| +181% | +$378K | 0.02% | 154 |
|
|
2022
Q4 | $204K | Buy |
370
+80
| +28% | +$42.4K | 0.01% | 186 |
|
|
2022
Q3 | $147K | Sell |
290
-610
| -68% | -$341K | 0.01% | 210 |
|
|
2022
Q2 | $489K | Buy |
+900
| New | +$495K | 0.02% | 175 |
|
|
2019
Q4 | – | Sell |
-482
| Closed | -$140K | – | 411 |
|
|
2019
Q3 | $140K | Buy |
482
+99
| +26% | +$28.3K | ﹤0.01% | 225 |
|
|
2019
Q2 | $112K | Buy |
383
+140
| +58% | +$38.6K | ﹤0.01% | 204 |
|
|
2019
Q1 | $67K | Sell |
243
-25
| -9% | -$6.22K | ﹤0.01% | 220 |
|
|
2018
Q4 | $60K | Sell |
268
-67
| -20% | -$15.7K | ﹤0.01% | 262 |
|
|
2018
Q3 | $82K | Buy |
+335
| New | +$77.1K | ﹤0.01% | 269 |
|
|
2017
Q1 | – | Sell |
-640
| Closed | -$90K | – | 649 |
|
|
2016
Q4 | $90K | Sell |
640
-580
| -48% | -$85.5K | 0.01% | 287 |
|
|
2016
Q3 | $194K | Sell |
1,220
-15,410
| -93% | -$2.37M | 0.02% | 255 |
|
|
2016
Q2 | $2.46M | Buy |
16,630
+12,630
| +316% | +$1.86M | 0.46% | 79 |
|
|
2016
Q1 | $566K | Buy |
+4,000
| New | +$536K | 0.1% | 171 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 745 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 701 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 580 |
|
Other funds holding TMO
